Ipsc-derived cardiac fibroblast extracellular matrix for cardiac cell therapy
Ended Project Grant Awarded Last action
- Award ID
- R43HL156351
- Recipient
-
Cellular Logistics, Inc. UEI C7M8MA1YGXP5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $962,034
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Funding
-
- $641,356.00 Federal
- $320,678.00 Non-federal
- Place of performance
- Sun Prairie, WI, USA
Award details come from USAspending.gov.
Description
- Abstract
- Cellular logistics' (CL) innovation in biomaterials offers a solution to the vexing problem of stem cell retention and integration in cardiovascular regenerative therapies. Despite great promise and >20 years of research, regenerative medicine-including stem cell therapies-has yet to demonstrate significant durable regeneration in the heart. Regenerating damaged heart muscle is a challenging and complex feat-simply providing an adequate in-situ dose has proven difficult, with
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $320,678 | $0 | |
| Original award | $320,678 | $320,678 |
Quick answers
Who received award R43HL156351?
R43HL156351 was awarded to Cellular Logistics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 1, 2021.
How much is award R43HL156351 worth?
$962,034 has been obligated on R43HL156351: $641,356 in federal funding and $320,678 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award